MIOTEPA 100 – Thiotepa for Injection USP 100 mg

Categories: Anticancer Products main, MBA Products Tags: anticancer product, healthcare product, mba pharmaceuticals pvt ltd, medicine, miotepa 100, miotepa injection, online pharmacy, pharma company, pharmaceutical, similar to tepadine, thiotepa 100 mg, thiotepa injection

Description
Reviews (0)

Description

MIOTEPA 100

Medicine composition: Thiotepa for Injection USP 100 mg

Dosage Form: Injection

Packing: 1*Vial

Market Authorization: MBA Pharmaceuticals Pvt Ltd

Country Of Origin: India

Similar to Tepadine

Description:

Thiotepa is indicated to reduce the risk of graft rejection when used in conjunction with high-dose Busulfan and cyclophosphamide as a preparative regimen for allogeneic hematopoietic progenitor (stem) cell transplantation (Hscn for pediatric patients with class3 beta-thalassemia.
Thiotepa is indicated for the treatment of adenocarcinoma of the breast or ovary.
Thiotepa is indicated for controlling intracavitary effusions secondary to diffuse or localized neoplastic diseases of various serosal cavities.
Thiotepa is indicated for treatment of superficial papillary carcinoma of the urinary bladder.

Reviews

There are no reviews yet.

Be the first to review “MIOTEPA 100 – Thiotepa for Injection USP 100 mg”